Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by barcodewhizon Sep 28, 2006 6:39pm
844 Views
Post# 11436409

RE: Paradigm reiterated BUY and 80 cent target

RE: Paradigm reiterated BUY and 80 cent target One of the things the report specifically mentions is the fact that the UK and Irish blood agencies have virtually shut down their own blood collection systems for fear over infectivity. As a result, they are forced to import costly blood and blood substitutes ... HUGE $$$... I think the fact that they are spending such huge money suggests that they can afford to pay quite a bit for the bags and still save money... Good situation for whoever grabs this market... and Pall's stumble sure puts PLI in a control position. I hate to say it, but this most recent development should almost be spurring a strategic interest in Prometic by PALL..or at least in the UK division..... especially given the huge value and market cap disparities... we would be a blip purchase for them. This SHOULD ultimately get reflected in PLI's market cap as the big boyz start to see the reality of the situation. This is where having JP Morgan and Third Point involved is a bonus for us.
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse